Cite

HARVARD Citation

    Pusceddu, S. et al. (2020). Are Cyclin‐Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?. Oncologist. pp. e1257-e1258. [Online]. 
  
Back to record